Section 26B-4-410 - [Effective Until 8/1/2024] Immunity from liability(1) The following, if acting in good faith, are not liable in any civil or criminal action for any act taken or not taken under the authority of Sections 26B-4-406 through 26B-4-411 with respect to an anaphylactic reaction or asthma emergency: (b) a physician, physician assistant, pharmacist, or any other person or entity authorized to prescribe or dispense prescription drugs;(c) a person who conducts training described in Section 26B-4-407 or 26B-4-408;(d) a qualified epinephrine auto-injector entity; and(e) a qualified stock albuterol entity.(2) Section 53G-9-502 does not apply to the administration of an epinephrine auto-injector or stock albuterol in accordance with this part.(3) This section does not eliminate, limit, or reduce any other immunity from liability or defense against liability that may be available under state law.Amended by Chapter TBD, 2024 General Session ,§ 5, eff. 5/1/2024.Renumbered from § 26-41-106 and amended by Chapter 307, 2023 General Session ,§ 134, eff. 5/3/2023.Amended by Chapter 236, 2019 General Session ,§ 7, eff. 7/1/2020.Amended by Chapter 415, 2018 General Session ,§ 26, eff. 3/22/2018.Amended by Chapter 332, 2015 General Session ,§ 5, eff. 5/12/2015.Amended by Chapter 64, 2008 General SessionThis section is set out more than once due to postponed, multiple, or conflicting amendments.